Association of Proton Pump Inhibitor Use With Incident Dementia and Cognitive Decline in Older Adults: A Prospective Cohort Study
Authors:
- 12 June 2023
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 165 (3) , 564-572.e1
Abstract
No abstract availableKeywords
Funding Information
- Boehringer Ingelheim
- National Institutes of Health (1127060, 1173690, 334047)
- National Health and Medical Research Council
- National Institute on Aging (RF1 AG067744)
- Monash University
- National Cancer Institute
- Bayer
- Victorian Cancer Agency
This publication has 32 references indexed in Scilit:
- Association of Proton Pump Inhibitors With Risk of DementiaJAMA Neurology, 2016
- Risk of dementia in elderly patients with the use of proton pump inhibitorsEuropean Archives of Psychiatry and Clinical Neuroscience, 2014
- Defensive Effect of Lansoprazole in Dementia of AD Type in Mice Exposed to Streptozotocin and Cholesterol Enriched DietPLOS ONE, 2013
- Heart disease as a risk factor for dementiaClinical Epidemiology, 2013
- Vitamin B12status, cognitive decline and dementia: a systematic review of prospective cohort studiesBritish Journal of Nutrition, 2012
- Race, Ancestry, and Development of Food-Allergen Sensitization in Early ChildhoodPediatrics, 2011
- An operational approach to National Institute on Aging–Alzheimer's Association criteria for preclinical Alzheimer diseaseAnnals of Neurology, 2011
- Angiotensin-Converting Enzyme Inhibitors and Cognitive Decline in Older Adults With HypertensionArchives of internal medicine (1960), 2009
- Anti-inflammatory Drugs Protect Against Alzheimer Disease at Low DosesArchives of Neurology, 2000
- Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's diseaseNeurology, 1996